George Soros acquired 117 Thousand Intra-Cellular Therapies shares worth $15.4 Million. That's 0.46% of their equity portfolio (63rd largest holding). The first Intra-Cellular Therapies trade was made in Q3 2017. Since then George Soros bought shares one more times and sold shares on one occasions. The stake costed the investor $14.5 Million, netting the investor a gain of 6.3% so far.